
Roszet is a prescription medication that combines two powerful ingredients, Rosuvastatin and Ezetimibe, to effectively manage cholesterol levels in the body. This unique formulation works by reducing the amount of cholesterol produced by the liver and increasing the removal of cholesterol from the bloodstream.
USD $29.16
Rosuvastatin with Ezetimibe is a combination lipid-lowering therapy used to reduce low-density lipoprotein cholesterol (LDL-C) levels in patients with hypercholesterolemia or mixed dyslipidemia. It combines Rosuvastatin (a statin), which inhibits cholesterol synthesis in the liver, and Ezetimibe (a cholesterol absorption inhibitor), which reduces intestinal cholesterol absorption.
Brand Names:
Drug Classification:
References: FDA Roszet Prescribing Information, ClinicalTrials.gov
Rosuvastatin and Ezetimibe work through dual mechanisms to reduce LDL-C levels:
Rosuvastatin (Statin Action):
Ezetimibe (Cholesterol Absorption Inhibitor):
Clinical Studies: Studies like IMPROVE-IT and EXPLORER have demonstrated that Ezetimibe in combination with statins significantly lowers LDL-C compared to statin monotherapy.
References: PubMed, NEJM IMPROVE-IT Study
This combination is prescribed to:
✅ Treat primary hypercholesterolemia (including heterozygous familial hypercholesterolemia).
✅ Lower LDL-C in patients who require additional cholesterol reduction despite statin therapy.
✅ Reduce cardiovascular risks, including heart attacks and strokes, in high-risk patients.
✅ Manage mixed dyslipidemia, reducing triglycerides (TG) and increasing high-density lipoprotein cholesterol (HDL-C).
References: AHA/ACC Guidelines
Dosage Strengths:
Standard Dosing:
⚠ Special Considerations:
References: FDA Labeling, ClinicalTrials.gov
Who Should Take Rosuvastatin with Ezetimibe?
✔️ Adults with high cholesterol (LDL > 130mg/dL) despite diet and lifestyle modifications.
✔️ Patients with high cardiovascular risk (diabetes, hypertension, smoking history).
✔️ Individuals with familial hypercholesterolemia (genetically high cholesterol).
Who Should NOT Take It?
❌ Patients with active liver disease or persistently high liver enzymes.
❌ Pregnant or breastfeeding women (statins are teratogenic).
❌ Those with a known allergy to rosuvastatin or ezetimibe.
References: FDA Labeling, European Society of Cardiology Guidelines
Headache, dizziness, fatigue
Muscle pain (myalgia), joint pain
Abdominal pain, diarrhea, nausea
Increased liver enzymes
⚠ Rhabdomyolysis (severe muscle breakdown)
⚠ Liver toxicity (persistent nausea, dark urine, jaundice)
⚠ Severe allergic reaction (rash, swelling, breathing difficulty)
References: PubMed
⚠ Warnings:
⚠ Cautions:
References: NEJM, FDA Drug Warnings
Major Drug Interactions:
References: FDA Interaction Studies, PubMed
Q: How long does it take for Rosuvastatin with Ezetimibe to lower cholesterol?
✅ Most patients see a significant LDL reduction within 2–4 weeks of starting therapy.
Q: Can I take Rosuvastatin with Ezetimibe at night?
✅ Yes, but taking it at the same time daily is more important than the time of day.
Q: Does this combination increase the risk of diabetes?
✅ Statins may slightly raise blood glucose levels, but the cardiovascular benefits outweigh the risk.
Q: Can I stop Rosuvastatin with Ezetimibe once my cholesterol is normal?
No. Stopping the medication may cause LDL levels to rebound. Always consult your doctor before discontinuation.
References: AHA Guidelines
Rosuvastatin with Ezetimibe is a powerful combination therapy that effectively reduces LDL-C and cardiovascular risk. By combining statin action with cholesterol absorption inhibition, it offers superior cholesterol reduction over monotherapy. However, careful monitoring of liver function, muscle symptoms, and drug interactions is essential for safe use.
References: [FDA, PubMed, NEJM, AHA, ESC Guidelines]
Disclaimer: This guide is for educational purposes only. Always consult a healthcare provider before starting or modifying any medication regimen.